160 related articles for article (PubMed ID: 26325374)
1. Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication.
Daniels-Wells TR; Widney DP; Leoh LS; Martínez-Maza O; Penichet ML
J Immunother; 2015 Oct; 38(8):307-10. PubMed ID: 26325374
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Antibodies Targeting TfR1 in Xenograft Mouse Models of AIDS-Related Non-Hodgkin Lymphoma.
Daniels-Wells TR; Candelaria PV; Kranz E; Wen J; Wang L; Kamata M; Almagro JC; Martínez-Maza O; Penichet ML
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980702
[TBL] [Abstract][Full Text] [Related]
3. An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies.
Daniels TR; Ortiz-Sánchez E; Luria-Pérez R; Quintero R; Helguera G; Bonavida B; Martínez-Maza O; Penichet ML
J Immunother; 2011; 34(6):500-8. PubMed ID: 21654517
[TBL] [Abstract][Full Text] [Related]
4. Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV
Martínez LE; Daniels-Wells TR; Guo Y; Magpantay LI; Candelaria PV; Penichet ML; Martínez-Maza O; Epeldegui M
Mol Cancer Ther; 2021 Sep; 20(9):1592-1602. PubMed ID: 34158342
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis.
Suzuki E; Daniels TR; Helguera G; Penichet ML; Umezawa K; Bonavida B
Int J Oncol; 2010 May; 36(5):1299-307. PubMed ID: 20372806
[TBL] [Abstract][Full Text] [Related]
6. Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.
Daniels-Wells TR; Helguera G; Rodríguez JA; Leoh LS; Erb MA; Diamante G; Casero D; Pellegrini M; Martínez-Maza O; Penichet ML
Toxicol In Vitro; 2013 Feb; 27(1):220-31. PubMed ID: 23085102
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma.
Leoh LS; Kim YK; Candelaria PV; Martínez-Maza O; Daniels-Wells TR; Penichet ML
J Immunol; 2018 May; 200(10):3485-3494. PubMed ID: 29654211
[TBL] [Abstract][Full Text] [Related]
8. Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells.
Rodríguez JA; Luria-Pérez R; López-Valdés HE; Casero D; Daniels TR; Patel S; Avila D; Leuchter R; So S; Ortiz-Sánchez E; Bonavida B; Martínez-Maza O; Charles AC; Pellegrini M; Helguera G; Penichet ML
Leuk Lymphoma; 2011 Nov; 52(11):2169-78. PubMed ID: 21870996
[TBL] [Abstract][Full Text] [Related]
9. An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication.
Daniels-Wells TR; Candelaria PV; Leoh LS; Nava M; Martínez-Maza O; Penichet ML
J Immunother; 2020; 43(2):48-52. PubMed ID: 31693515
[TBL] [Abstract][Full Text] [Related]
10. Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.
Leoh LS; Morizono K; Kershaw KM; Chen IS; Penichet ML; Daniels-Wells TR
J Gene Med; 2014; 16(1-2):11-27. PubMed ID: 24436117
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.
Daniels TR; Ng PP; Delgado T; Lynch MR; Schiller G; Helguera G; Penichet ML
Mol Cancer Ther; 2007 Nov; 6(11):2995-3008. PubMed ID: 18025284
[TBL] [Abstract][Full Text] [Related]
12. Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.
Leoh LS; Daniels-Wells TR; Martínez-Maza O; Penichet ML
Mol Immunol; 2015 Oct; 67(2 Pt B):407-15. PubMed ID: 26232328
[TBL] [Abstract][Full Text] [Related]
13. Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor.
Rodríguez JA; Helguera G; Daniels TR; Neacato II; López-Valdés HE; Charles AC; Penichet ML
J Control Release; 2007 Dec; 124(1-2):35-42. PubMed ID: 17884229
[TBL] [Abstract][Full Text] [Related]
14. Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief Communication.
Candelaria PV; Nava M; Martínez-Maza O; Daniels-Wells TR; Penichet ML
J Immunother; 2022 Jun; 45(5):227-230. PubMed ID: 35467582
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species.
Ortiz-Sánchez E; Daniels TR; Helguera G; Martinez-Maza O; Bonavida B; Penichet ML
Leukemia; 2009 Jan; 23(1):59-70. PubMed ID: 18946492
[TBL] [Abstract][Full Text] [Related]
16. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
Shimosaki S; Nakahata S; Ichikawa T; Kitanaka A; Kameda T; Hidaka T; Kubuki Y; Kurosawa G; Zhang L; Sudo Y; Shimoda K; Morishita K
Biochem Biophys Res Commun; 2017 Mar; 485(1):144-151. PubMed ID: 28189691
[TBL] [Abstract][Full Text] [Related]
17. An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.
Ng PP; Dela Cruz JS; Sorour DN; Stinebaugh JM; Shin SU; Shin DS; Morrison SL; Penichet ML
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10706-11. PubMed ID: 12149472
[TBL] [Abstract][Full Text] [Related]
18. Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.
Ng PP; Helguera G; Daniels TR; Lomas SZ; Rodriguez JA; Schiller G; Bonavida B; Morrison SL; Penichet ML
Blood; 2006 Oct; 108(8):2745-54. PubMed ID: 16804109
[TBL] [Abstract][Full Text] [Related]
19. A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.
Neiveyans M; Melhem R; Arnoult C; Bourquard T; Jarlier M; Busson M; Laroche A; Cerutti M; Pugnière M; Ternant D; Gaborit N; Chardès T; Poupon A; Gouilleux-Gruart V; Pèlegrin A; Poul MA
MAbs; 2019 Apr; 11(3):593-605. PubMed ID: 30604643
[TBL] [Abstract][Full Text] [Related]
20. Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.
Candelaria PV; Leoh LS; Penichet ML; Daniels-Wells TR
Front Immunol; 2021; 12():607692. PubMed ID: 33815364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
